fda glp-1 warning october 2025 Issues Warnings Against Illegal Marketing GI Adverse Effects of Glucagon-Like

What Is Retatrutide Retatrutide is Eli Lilly's experimental drug for obesity and related conditions

After that, each refill including physician review, a personalized plan, a detailed metabolic report, and shipping runs $299

Respondents had an average age of 42.6 years and were 54.4% female, 45.1% male, and 0.5% nonbinary, representing all 50 states and the District of Columbia

Yet, it also casts a shadow

The Plaintiff's purchases of stock also occurred during this time, including a transaction on July 14, 2025

The new notice requires that the reason for use field in such reports explicitly state off-label use (cosmetic purpose). This creates a formal government tracking system for adverse events arising from cosmetic GLP-1 use